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Abstract
The presence of protein aggregates in cells is a known feature of many human age-related
diseases, such as Huntington’s disease. Simulations using fixed parameter values in a model of
the dynamic evolution of expanded polyglutamine (PolyQ) proteins in cells have been used to
gain a better understanding of the biological system, how to focus drug development and how to
construct more efficient designs of future laboratory-based in vitro experiments. However, there
is considerable uncertainty about the values of some of the parameters governing the system.
Currently, appropriate values are chosen by ad hoc attempts to tune the parameters so that the
model output matches experimental data. The problem is further complicated by the fact that
the data only offer a partial insight into the underlying biological process: the data consist only
of the proportions of cell death and of cells with inclusion bodies at a few time points, corrupted
by measurement error.
Developing inference procedures to estimate the model parameters in this scenario is a signif-
icant task. The model probabilities corresponding to the observed proportions cannot be evalu-
ated exactly and so they are estimated within the inference algorithm by repeatedly simulating
realisations from the model. In general such an approach is computationally very expensive and
we therefore construct Gaussian process emulators for the key quantities and reformulate our
algorithm around these fast stochastic approximations. We conclude by examining the fit of our
model and highlight appropriate values of the model parameters leading to new insights into
the underlying biological processes such as the kinetics of aggregation.
Keywords: Gaussian process emulator; history matching; MCMC; optimal design; stochastic
kinetic model.
1 Introduction
One of the main aims of modelling biological systems is to describe and understand the temporal
evolution of the system taking account of the potentially complex inter-relationships between com-
ponents within the system. Models can also be used to facilitate in silico experiments in which
virtual experiments are performed on a computer. These in silico experiments have an advantage
over laboratory-based experiments as, in general, they are much cheaper and faster to conduct.
This can lead to a better understanding of, for example, the biological system, how to focus drug
development and how to construct more efficient designs of future laboratory-based in vitro exper-
iments.
The accumulation of abnormal protein deposits within cells are hallmarks of neurodegenera-
tive diseases affecting humans as they age. There are many such diseases, (e.g. Alzheimers and
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Parkinsons disease), in which different parts of the brain are affected resulting in a range of clinical
symptoms such as loss of motor function, dementia, and behavioural changes. Despite differences
between symptoms, there are similarities in the underlying molecular mechanisms leading to the
accumulation of protein aggregates and the neuronal cell death (Gan, Cookson et al. 2018). Al-
though, age is the greatest risk factor for neurodegeneration, there is a group of diseases that are
caused by genetic mutations. In nine of these diseases, the mutation occurs in a gene that contains
a repeat of a CAG nucleotide triplet (Lieberman, Shakkottai et al. 2019). As CAG encodes for
the amino acid glutamine, these diseases are known as polyglutamine diseases and the proteins
they encode are referred to as PolyQ proteins, although different genes and proteins are involved
in each disease, e.g. Huntingtons disease (HD), (Lieberman, Shakkottai et al. 2019). HD is an
adult-onset, progressive disease characterised by loss of motor function, psychiatric disorders and
dementia (McColgan and Tabrizi 2018). In this disease, the CAG triplet is found in the huntingtin
gene (HTT, HGNC:4581). In the normal HTT gene, the CAG triplet is repeated 10-35 times but in
the mutated form, the segment is expanded from 36 to over 120 repeats. This leads to the forma-
tion of an abnormally long protein which may be cleaved within the cell into small toxic fragments
that enter the nucleus where they form aggregates, known as inclusion bodies (or inclusions), and
sequester other proteins causing transcriptional dysregulation although the exact mechanisms of
how this occurs are still unknown (McColgan and Tabrizi 2018). In addition, huntingtin fragments
form aggregates in the cytoplasm and may impair cellular function, e.g. impairment of proteostasis
(McColgan and Tabrizi 2018).
There are currently no effective interventions for the prevention, delay in onset or slowing down
of disease progression in HD or in any other neurodegenerative disorder. This is mainly due to a
lack of a full understanding of the underlying molecular mechanisms. In particular, although pro-
tein aggregation is a common feature of all these disorders, it is still not fully known how protein
aggregates actually contribute to the disease process. There has been considerable controversy over
which stage of the aggregation process is most toxic to cells, and it has been suggested that the for-
mation of large inclusion bodies may be protective as they sequester misfolded proteins and prevent
the overload of protein degradation pathways (Ross and Poirier 2004). This has been shown exper-
imentally in cell culture (Arrasate, Mitra et al. 2004). However, this protective effect may only be
short-term, as large aggregates also contain proteins involved in the removal and repair of damaged
protein and it has been suggested that they may induce quiescence and induction of cell death via
necrosis (Ramdzan, Trubetskov et al. 2017), which can cause damage to neighbouring cells. In ad-
dition, nuclear inclusions may impair redox signalling leading to an increase in oxidative stress and
further damage (Paul and Snyder 2019). The controversy regarding cytoxicity of PolyQ proteins is
largely due to insufficient understanding of the molecular mechanisms involved. This motivated our
previous study which used live cell imaging with fluorescent reporter systems to examine the rela-
tionship between PolyQ protein, activation of the stress kinase p38MAPK (MAPK14; HGNC:6876
), reactive oxygen species (ROS) generation, inhibition of the proteasome (a protein complex which
degrades cellular proteins), and formation of PolyQ nuclear inclusions (Tang, Proctor et al. 2010).
It was found that proteasome inhibition usually preceded formation of inclusion bodies and that
p38MAPK inhibitors alleviated the inhibition of proteasomes and delayed the onset of inclusion
formation. Conversely, the addition of proteasome inhibitors resulted in earlier formation of inclu-
sions. This study also included a computational model which explored the complex interactions
of PolyQ proteins with other elements of the cell and they used computer simulations from the
model (with fixed parameter values) to suggest ways to reduce the toxicity of PolyQ proteins on
cells. As their model describes dynamic interactions at the single cell level, the number of different
biochemical species vary discretely over time, often with low copy numbers (Gillespie, 1977). Also
the interaction of the species is driven by Brownian motion and so accurate modelling requires that
it take account of the inherent stochasticity present in the system.
Currently, plausible values for the parameters in the PolyQ model are determined by using
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model simulations for specified values of the parameters and then adjusting them in an attempt to
match experimental data. Clearly this is a difficult task and one with which statisticians can make
a contribution. The general scenario of modelling biological systems in computational systems
biology is described by Kitano (2001) with increasing focus on those describing the stochastic
dynamics of individual cells (Elowitz et al., 2002; Swain et al., 2002). More recently an overview
of this area has been provided by Villaverde and Banga (2014).
A key difficulty in conducting parameter inference for complex stochastic models such as the
PolyQ model is that the experimental data are typically incomplete and subject to measurement er-
ror. This necessitates the use of computationally intensive schemes such as Gibbs sampling (Boys
et al., 2008), pseudo-marginal Metropolis-Hastings (Golightly and Wilkinson, 2011; Georgoulas
et al., 2016; Wilkinson, 2018), population Monte Carlo (Koblents and Mı´guez, 2015; Koblents
et al., 2019) and approximate Bayesian computation (Wu et al., 2014; Owen et al., 2015). Inference
is particularly challenging for the PolyQ model since the data consist only of the proportion of
cells which are dead and the proportion of cells which contain inclusion bodies. Since the corre-
sponding model probabilities are intractable, these latent proportions must be estimated at each
observation time by repeatedly forward simulating the model over the duration of the time-course.
Computational cost can be reduced by replacing the expensive and exact stochastic simulator with
a cheap approximation. For example, approaches which replace the continuous-time stochastic
model with a discrete-time approximation include tau-leaping (Gillespie, 2001; Cao et al., 2006)
and the chemical Langevin equation (Gillespie, 2000; van Kampen, 2001).
1.1 Contributions and organisation of the paper
The aim of this paper is to examine what insight the limited available experimental data provides
about the PolyQ model parameters and to check whether the model gives a reasonable description
of the dynamic variation observed in the experimental data.
Given the prohibitive computational cost associated with fitting the stochastic polyQ model, we
consider a computationally feasible approximation and perform exact (simulation-based) inference
for the resulting model. We eschew the use of an approximate simulator in favour of directly emu-
lating the empirical logit of the proportions of interest with a Gaussian process (GP) (Rasmussen
and Williams, 2006; Santner et al., 2003). In particular, combining the fitted GP emulator with
a Gaussian measurement model (on the same scale as the observed data) allows a direct approxi-
mation of the observed data likelihood without recourse to further simulation from the stochastic
PolyQ model.
The findings from this analysis give new information regarding the parameters of the model,
which in turn leads to new insights into the underlying biological processes. For example, this
analysis has shown that during the first stages of the aggregation process both aggregation and
disaggregation probably occur much faster and that the disaggregation/aggregation ratio is likely
to be a magnitude higher than was originally assumed. The biological implication of this is that it
will take longer to reach the threshold size required for inclusion formation but that there will also
be higher levels of small aggregates which will inhibit the proteasome.
The remainder of the paper is organised as follows. Section 2 details the experimental data
available and outlines how it was collected. A complete description of the model is given in section 3
which includes the underlying stochastic model which describes the dynamic evolution of this
biological process and the observation model, which links the data to the underlying process. Our
prior assumptions about parameter values and initial levels are given in 4. A method for determining
the posterior distribution for model quantities is described in section 5 and, because a standard
simulation-based MCMC solution is prohibitively expensive, we develop Gaussian process emulators
in section 6 which facilitate timely generation of realisations from the posterior distribution. As
we have high prior uncertainty on model parameters, in section 7 we employ a history matching
technique which removes implausible training points in an attempt to fit the GPs within regions
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of non-negligible posterior support. We also include an assessment of the quality of the final fitted
GPs. We present our findings about the the PolyQ model in section 8, and point out new insights
into this biological system.
2 Experimental data
We have data from two different sets of experiments. These were carried out in the same laboratory
and are described briefly below. A more comprehensive description of the experimental procedures
can be found in Tang et al. (2010).
2.1 Cell death
The first experiment begins with a large number of human U87MG glioblastoma cells maintained
in a suitable medium at 37◦C at 5% CO2. The cells are transfected with a construct that contains
the expanded PolyQ Huntington protein (see section 2.2 for details). The survival of cells is
monitored over time. Three different repeats of the experiment are carried out under the following
experimental conditions:
(i) Control group: No intervention.
(ii) Proteasome inhibition group: Cells are treated with a proteasome inhibitor 24 hours after
transfection. The stochastic kinetic model captures this scenario by reducing the initial value
kproteff = 1 to kproteff = 0.05 after 24 hours.
(iii) p38 inhibition group: Cells were pre-treated for 2 hours with a p38 inhibitor. The stochastic
kinetic model captures this scenario by setting kp38act = 0.05.
The changes to parameter values used to describe the different experimental conditions were de-
termined by conversations with the experimentalists. It was felt that reducing the rates to zero in
conditions (ii) and (iii) overstated the effect of the experimental treatment and so these rates are
set to low but non-zero values.
The cells are stained with propidium iodide, which is a fluorescent dye with the property that
it only binds to non-viable (dead) cells. This technique is called propidium iodide exclusion and
is used to identify the viability of the cells over time. The fluorescent dye can be viewed under
a microscope and estimates of the proportion of cell death can be observed over time. These
proportions of cell death form our experimental data which can be seen in Table 1. Each row of the
table corresponds to experiments carried out under the different experimental conditions outlined
above. We have two repeats of each experiment.
Within the stochastic model, cell death can occur via two biological pathways, either via pro-
teasome inhibition or by p38 activation. This process is monitored within the model by using the
dummy species PIdeath and p38death. These species are both binary variables, with a zero value
representing that the cell is alive.
2.2 Inclusion body formation
Experimentalists monitor the number of cells with inclusion bodies by first creating a construct that
encodes an expanded PolyQ Huntington protein which is tagged with Yellow Fluorescent Protein
(YFP). U87MG cells are transfected with the construct and then imaged at 10 minute intervals
between 24 to 48 hours after transfection. Time lapse images reveal the formation of inclusions
(by detecting YFP) and the percentage of cells with inclusions is recorded every 6 hours. The
experimental results are given in Table 2. As with the data on cell death, each row corresponds to
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Table 1: Proportions of cell death observed under different experimental conditions.
Condition 24hrs 36hrs 48hrs
(i) 0.1503 0.1455 0.2608
0.1788 0.1821 0.2846
(ii) 0.1897 0.1807 0.2250
0.1640 0.1973 0.2998
(iii) 0.2168 0.2344 0.3644
0.2436 0.2095 0.3872
Table 2: Proportions of inclusion bodies observed under different experimental conditions.
Condition 24hrs 30hrs 36hrs 42hrs 48 hrs
(i) 0.0909 0.2857 0.3824 0.4286 0.7273
0.0175 0.2131 0.3538 0.4304 0.5742
(ii) 0.0909 0.4247 0.6125 0.7403 0.8194
0.1154 0.5075 0.7895 0.8667 0.9157
(iii) 0.0303 0.0444 0.0612 0.1373 0.2200
0.0189 0.0938 0.1286 0.1613 0.1833
experiments carried out under different experimental conditions and we have two repeats of each
experiment.
Within the stochastic model, the number of cells containing inclusions is counted via the number
of cells containing SeqAggP. In the laboratory, image analysis suffers from a thresholding problem
in detecting inclusions and we capture this aspect by defining cells with inclusions as those in which
SeqAggP contains more than ten PolyQ proteins (i.e. SeqAggP > 10). The value of this threshold is
based on the biological modeller’s best understanding of the mechanism, though in fact the actual
value is not crucial since aggregates grow very rapidly and there is only a very small timeframe
when SeqAggP is less than ten.
3 The stochastic model
3.1 PolyQ mechanism
The stochastic model for the PolyQ mechanism we consider in this paper is a reduced form of that
proposed by Tang et al. (2010). The original model developed by Tang et al. (Tang, Proctor et
al. 2010) was constructed in the Systems Biology Markup Language (SBML) and is available from
the Biomodels database (Li, Donizelli et al. 2010) (Model ID: BIOMD0000000285). The model
was developed to investigate the effects of PolyQ on proteasome function, oxidative stress, and cell
death. It contained a pool of PolyQ which was continually turned over, being degraded by the
proteasome. It was assumed that the PolyQ aggregation process started by two monomers inter-
acting, which then interacts with further monomers causing the aggregate to grow (AggPolyQ1-5).
At early stages, it was assumed that disaggregation could also take place but that when the ag-
gregate reached a threshold size (denoted by SeqAggP in the model), disaggregation does not take
place, so that the aggregate continues to grow and an inclusion forms. The model also included a
generic pool of protein which could be damaged by ROS leading to misfolding and aggregation. It
was assumed that small aggregates bind to the proteasome but cannot be degraded and so inhibit
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Figure 1: Example data from live cell imaging.
proteasome function. In addition, they may increases levels of ROS. The model also included the
stress kinase p38MAPK (simply modelled as two pools: inactive [p38] and active [p38P]) with acti-
vation occurring more frequently when levels of ROS are high (Sato, Okada et al. 2014), and that
high levels of p38P activated a cell death pathway (denoted by p38death). Proteasomes bound by
aggregates (AggPProteasome) could also activate a cell death pathway (denoted by PIdeath). The
model also included the turnover of a fluorescent protein (mRFPu) as an increase in mRFPu levels
indicates that the proteasome is inhibited, shown by live cell imaging in Tang et al. 2010. An
example of this data is shown in Figure1.
Given the complexity of the original model (with 27 chemical species and 72 reactions) it
was necessary to consider a simplification for this study. The changes to the Tang model have
been to reduce the number of species and reactions by removing the generic pool of protein and its
associated reactions of misfolding and aggregation, and by removing the fluorescent protein mRFPu,
which had been originally included as a marker of proteasome function. In the process of model
construction, it was found neccesary to add in an effect of ROS on the aggregation process. The
experimental biologists suggested that ROS increases the propensity of PolyQ proteins to aggregate
due to ROS interfering with the ubiquitin-proteasome system (UPS), so that PolyQ proteins are
more likely to aggregate than be degraded when ROS levels are high. The exact mechanism is not
fully understood and so we simply included ROS in the rate laws for PolyQ aggregation.
The resulting reduced model contains 14 chemical species and 33 reaction channels, which is
still relatively large when compared to other stochastic kinetic models for which fully Bayesian
inference is available in the literature (Boys et al., 2008; Henderson et al., 2010). A complete list of
the reactions and their stochastic rate laws describing the PolyQ model can be found in Appendix A
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Table 3: Parameters in the PolyQ model under condition (i) with their known values
Parameter Value Units Reference
ksynPolyQ 0.25 molecule s
−1 Calculated from value of kdegPolyQ to give
steady state level of 1000 molecules
kdegPolyQ 2.5× 10−7 molecule−1s−1 Half-life of 30 hours (Persichetti et al., 1996)
kactp38 2× 10−3 molecule−1s−1 Phosphorylation occurs within
(Aoki,Takahashi et al. 2013)
kp38act 1.0 dimensionless Dummy variable (set to 0.05 for p38 inhibition)
kproteff 1.0 dimensionless Dummy variable (set to 0.05 for proteasome
inhibition)
of the Supplementary Materials. All reactions except those relating to aggregation follow the law
of mass action kinetics. We used a Hill function for the effects of ROS as it is thought that low
levels of ROS would have little effect on the UPS with a maximal effect when ROS levels are high.
We assumed that the rate of aggregation would be half the maximal rate when ROS is at its basal
level, which is achieved by using the value 10 in the denominator of the rate law.
The model is represented graphically in Figure 2, where oval shapes (nodes) represent chemical
species and an arrow between two nodes represents a reaction which can take place involving the
two chemical species. The figure clearly shows the complex interlinkages and complex feedback
loops within the model.
3.2 The observation model
We assume that the experimental data are noisy versions of the equivalent quantities in the stochas-
tic model and adopt a simple model for this observation error which is additive independent normal
noise on a logit scale (as the data are proportions). Other error models are possible, such as em-
bedding the model probabilities within a Beta distribution, but this logistic normal model affords
advantages in the subsequent analysis.
Suppose the stochastic model for the experiment run under condition c with parameter vector
θ gives pDt,c(θ) and p
I
t,c(θ) as the probabilities of death and of the presence of inclusions at time t
and the logits of their observed versions as yDt,c,r and y
I
t,c,r in experimental repeat r. We assume the
observation model is, for c = 1, 2, 3, r = 1, 2
yDti,c,r = logit p
D
ti,c(θ) + σDεi,c,r, i = 1, 2, 3
yIti,c,r = logit p
I
ti,c(θ) + σIε
∗
i,c,r, i = 1, . . . , 5
where the εi,c,r and ε
∗
i,c,r are i.i.d. standard normal quantities and ti denote the ith time-point
at which an observation is available. Note that this model assumes the same measurement error
distribution for each experimental condition and repeat. The implications of this observation model
on the probability scale is explored in Appendix B of the Supplementary Materials.
4 Prior information
Tables 3 and 4 contain a list of all parameters in the model. Some parameters are known quite
accurately in the literature. For example, the synthesis and degradation rates of PolyQ proteins
ksynPolyQ and kdegPolyQ can be obtained by considering the half-life of PolyQ proteins (Persichetti
et al., 1996).
Also, to reduce the number of parameters in the model, it was thought reasonable to fix some
rates to be identical to others or to be functions of other rates. For example, the disaggregation
7
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Figure 2: Network diagram of the PolyQ model
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Table 4: Parameters in the PolyQ model under condition (i) with their prior distribution.
Parameter Prior distributions
kaggPolyQ θ1 = log kaggPolyQ ∼ N(log 10−7, 5)
kdisaggPolyQ1 θ2 = log kdisaggPolyQ1 ∼ N(log(5× 10−7), 5)
kseqPolyQ θ3 = log kseqPolyQ ∼ N(log(8× 10−7), 5)
kinhprot θ4 = log kinhprot ∼ N(log(5× 10−9), 5)
kremROS θ5 = log kremROS ∼ N(log(2× 10−4), 5)
kgenROSSeqAggP θ6 = log kgenROSSeqAggP ∼ N(log(10−7), 5)
kgenROSAggP θ7 = log kgenROSAggP ∼ N(log(5× 10−6), 5)
kinactp38 θ8 = log kinactp38 ∼ N(log 0.8, 5)
kgenROSp38 θ9 = log kgenROSp38 ∼ N(log(7× 10−7), 5)
kp38death θ10 = log kp38death ∼ N(log(9× 10−8), 5)
kPIdeath θ11 = log kPIdeath ∼ N(log(2.5× 10−8), 5)
σD σD ∼ InvChi(2, 0.12)
σI σI ∼ InvChi(0.75, 0.05)
rates for different sized PolyQ aggregates have been fixed as known proportions of the rate for
single PolyQ aggregates: kdisaggPolyQ2 = 0.8 kdisaggPolyQ1, kdisaggPolyQ3 = 0.6 kdisaggPolyQ1, and so
on. In each case, these identities or fixed proportions have been chosen according to the biological
modeller’s best understanding of the reaction system.
Only limited information is available for the remaining stochastic rate parameters and we rep-
resent these fairly weak prior beliefs using independent log-normal distributions with medians set
at our biological modeller’s best guess. On the log scale, the kinetic rate parameters are denoted
by θ1, . . . , θ11 and these parameters have independent normal prior distributions. The weak beliefs
are represented by prior variances of five on the log scale as these correspond to a plausible range
of values for the (untransformed) kinetic rates from 0.01 to 100 times their median value.
We have prior beliefs for the level of measurement error in the cell death experiments (σD)
from time course data on two independent replicates from an independent (but similar) study
measuring cell death proportions. The difference between these replicates on the logit scale form a
random sample from a N(0, σ2D) distribution and so these logit differences lead to an inverse gamma
posterior for σ2D under a vague prior. This posterior corresponds to an inverse chi distribution for
σD, where this distribution is defined as that of 1/
√
X, where X has a gamma distribution. Further,
as these data arise from a similar but different study, we choose to construct our prior as a powered
down version of this inverse chi posterior as this makes it more diffuse around an appropriate value
(Ibrahim and Chen, 2000). Our knowledge about the level of measurement error in the inclusion
body experiments is weaker and so we use an even more powered down prior for σI .
There is also uncertainty about some of the initial levels of the different species. This uncertainty
is captured by independent prior distributions elicited from the biological modeller. Other specie
levels are known due to the construction of the experiment, such as those for AggPolyQ1–AggPolyQ5,
others obey a conservation law (p38+p38P = 100) and some levels, such as that for this conservation
level and for PolyQ, set at fairly arbitrary high values reflecting the relative abundance of these
species within the cell. The values or prior distribution of the initial levels are listed in Table 5. Note
that two of these initial levels have a discrete log-normal DLN prior distribution, with probability
function pi(i) = Pr(i− 0.5 < X < i+ 0.5), where X is a log-normal random variable.
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Table 5: Value or prior distribution of the initial levels of the chemical species
Name Value or prior distribution
PolyQ 1000
Proteasome DLN(6.9, 0.12)
AggPolyQ1−5 0
SeqAggP 0
AggPProteasome 0
ROS DLN(2.5, 0.252)
p38P U{0, 1, . . . , 5}
p38 100-p38P
PIdeath 0
p38death 0
5 Posterior inference
Knowledge of the kinetic rates θ and the observation error levels σ = (σD, σI) is summarised in
the posterior distribution, which has density
pi(θ,σ|y) ∝ pi(θ)pi(σ)pi(y|θ,σ),
where y represents the collection of all data on cell death and inclusions. Although the normal
likelihood has a simple form, it does require calculation of the probabilities pDt,c(θ) and p
I
t,c(θ).
Unfortunately analytic expressions for these probabilities are not available due to the complexity of
the stochastic model. Prior uncertainty around the initial specie levels x0 is a further complicating
factor as, for example, pDt,c(θ) = Ex0{pDt,c(θ,x0)}, where Ex0{·} denotes expectation with respect
to x0. Therefore we estimate these probabilties using n independent realisations of the stochastic
model, initialised according to the prior distribution on initial levels. Suppose that a typical
probability is estimated by the proportion p̂n. For sufficiently large n, the empirical logit of such
proportions elogit p̂n = log{(p̂n + 0.5/n)/(1− p̂n + 0.5/n)} is unbiased for logit p and its sampling
variability is closely described by a normal distribution with variance 1/{np̂n(1−p̂n)}. Thus, taking
an improper constant prior for logit p gives its posterior distribution as a normal distribution with
mean elogit p̂n and variance 1/{np̂n(1− p̂n)}. Therefore we can integrate out posterior uncertainty
about logit p in the observation model, modifying it to have independent components of the form
y ∼ N(elogit p̂n(θ), σ2 + 1/[n p̂n(θ){1− p̂n(θ)}]).
Building an MCMC inference scheme around this normal likelihood is straightforward. We found
that estimating the probabilities using n = 1000 model simulations gave empirical logits which
fitted well to a normal distribution. Note that, in order for these estimates to be uncorrelated, they
have each been calculated using independent realisations of the model.
Unfortunately the MCMC scheme requires the generation of many millions (or even billions)
of realisations from the stochastic model as it explores the posterior distribution. Clearly this
problem prohibits using such a scheme for obtaining realisations from the posterior distribution in
a timely manner. In such situations it is commonplace to use stochastic approximations for these
deterministic model probabilities. We will use Gaussian process (GP) approximations (sometimes
called emulators) which are popular in the deterministic computer model literature and elsewhere.
Useful background articles in this area are Santner et al. (2003) and Bayarri et al. (2007). The
suitability of GPs as emulators is highlighted in O’Hagan (2006). Also see Henderson et al. (2009)
for an illustration of the utility of GP emulators in the analysis of complex biological models.
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6 Emulation
We need to build GP emulators approximating the stochastic output of the proportion of cell death
and that of inclusions under the three different conditions. Time (t) is an input variable in these
six emulators, in addition to the unknown stochastic rate constants (θ) and observation error levels
(σ). However, it can be problematic to specify appropriate covariance kernels over time. In any
case, for Bayesian inference, all that is needed are emulators for the distributions of the probabilities
under each experimental condition at the distinct time points ocurring in the datasets. Therefore
we will build a total of 24 emulators: 9 for proportions of cell death and 15 for proportions of
inclusion bodies. Using these time-condition-specific emulators also has the advantage that they
can be built in parallel. Thus we build GP emulators for
xDti,c(θ) = elogit p̂
D
ti,c(θ) i = 1, 2, 3
and
xIti,c(θ) = elogit p̂
I
ti,c(θ) i = 1, . . . , 5,
for each condition c = 1, 2, 3. The aim is to replace the empirical proportions in the observation
model with GP emulators, allowing for their uncertainty. Fortunately this is straightfoward as
each emulator prediction is also normally distributed and so, as before, the additional uncertainty
introduced by the GPs can be integrated out analytically and there is no need for the MCMC
scheme to integrate over an additional latent layer within the model.
6.1 Training data
In order to build the emulators for the xDti,c(θ) and x
I
ti,c(θ), we first need to evalute their values
at some set of chosen values for θ. This amounts to choosing the size and values in an nd-point
design Θ = (θ1, . . . ,θnd). In common with other work in this area (Santner et al., 2003; Henderson
et al., 2010) we choose to base our design on a Latin hypercube design (LHD) constructed using
the maximin algorithm of Morris and Mitchell (1995). These designs are popular as they produce
an effective and efficient coverage of a bounded space. We take the bounded space to be the
central hypercube of the prior distribution defined by the marginal 99% intervals for the rates θj .
Inevitably, determining an appropriate design from which to contruct GP emulators is a sequential
process. This is because it is not unusual to find that there are only a few design points in the
region of high posterior support, particularly when the marginal priors have large uncertainty (as
we have here). To help with this problem, as part of the sequential building of the emulators,
we filter out design points which are implausible (inconsistent with the data) by using a history
matching technique (see section 7). Note that obtaining estimates at each point in the LHD for
the proportions of cell death and of inclusions over repeated simulations of the stochastic model is
easily parallelisable on a high performance computer system.
6.2 Mean function and covariance function
The mean function was taken as a linear predictor in the components of θ, with the least squares
estimates as the coefficients. Thus each emulator has a mean function at input θ = (θ1, . . . θ11)
T
of the form
m(θ) = βˆ0 +
11∑
i=1
βˆiθi.
This choice was taken to give a parsimonious yet reasonably well fitting mean function and essen-
tially leaves the residuals to this fit being modelled by a zero mean function Gaussian process. As is
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commonly used in the emulation literature, we specified a squared exponential covariance function,
with
K(θi,θj |a, r) = a exp
{
−
11∑
k=1
r2k(θik − θjk)2
}
where, for example, θik denotes the kth component of θi. The parameters of this function control
the overall level of variability and smoothness of the process, with smaller values of the inverse
length scales rk giving smoother realisations.
6.3 Hyperparameter estimation
The hyperparameters a and r = (ri) for each emulator need to be estimated from the training
data before we can use them as part of the MCMC inference scheme. When fitting a typical
GP to training data x(Θ) = (x(θ1), . . . , x(θnd))
T , the likelihood for the hyperparameters results
from x(Θ)|a, r ∼ Nnd(m(Θ),K(Θ,Θ|a, r)) where Nnd(·, ·) denotes an nd-dimensional Gaussian
distribution and K(Θ,Θ|a, r)ij = K(θi,θj |a, r). In general it is not possible to obtain a posterior
distribution in closed form for a prior on (a, r). Here we take independent weak log-normal prior
distributions for the hyperparameters, with a ∼ LN(0, 100) and ri ∼ LN(0, 100), i = 1, . . . , 11. The
GPs were fitted by using the ‘no-U-Turn’ Hamiltonian Monte Carlo sampler and implemented via
the RStan package interface to the Stan package (Carpenter et al., 2017; Stan Development Team,
2018).
6.4 Modified observation model
For a typical GP, the prediction at a point θ† has distribution
x(θ†) ∼ N(m∗(θ†), v∗(θ†)) (1)
where
m∗(θ†) = m(θ†) +K(θ†,Θ)K(Θ,Θ)−1{x(Θ)−m(Θ)}
v∗(θ†) = K(θ†,θ†)−K(θ†,Θ)K(Θ,Θ)−1K(θ†,Θ)T .
Strictly speaking, this emulator distribution is a function of the GP hyperparameters and so we
should average over their posterior uncertainty. However, we have found that there is little gain
in doing this over using a delta approximation in which the hyperparameters are fixed at their
posterior mean.
We can incorporate the stochastic approximation of the GP emulator to elogit p̂n into our
observation model and integrate it out to give a model with independent components of the form
y ∼ N(m∗(θ), σ2 + v∗(θ) + 1/[n p∗n(θ){1− p∗n(θ)}])
where
p∗n(θ) = eexpit(θ) = {em
∗(θ)(1 + 0.5/n)− 0.5/n}/{1 + em∗(θ)}
is the GP prediction at point θ on the probability scale.
7 History matching and validation
It is quite likely that large parts of parameter space will give rise to model outputs which are
incompatible with the observed proportions. In practice, we need our Gaussian processes to be
accurate over regions of parameter space with non-negligible posterior support and so time spent
fitting them in regions of negligible posterior support is wasted. We can target the building of our
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Figure 3: Flow chart showing the work flow involved in iteratively fitting Gausian process emulators.
GPs within regions of non-negligible posterior support using methods known as history matching
(Cumming and Goldstein, 2010; Vernon et al., 2014). These methods work by determining which
design points are implausible before undertaking the computationally intensive task of evaluating
the model output (here empirical logits) at these points. After fitting a GP over, implausible design
points are determined by comparing data points yi with their GP prediction. An implausibility
measure at data point yi takes the form
Ii(θ) =
|yi −m∗(θ)|√
σ2 + v∗(θ) + 1/[n p∗n(θ){1− p∗n(θ)}]
.
Adopting a conservative strategy, the implausibility measure over the entire data set is calculated
as I(θ) = maxi Ii(θ). Large values of I(θ) indicate that θ is an implausible point in parameter
space. It is common to declare points as implausible if I(θ) > 3, this threshold being determined
using Pukelsheim’s 3-sigma rule. Notice that the implausibility measure requires a value to be given
for the measurement error level. We take the upper 1% value of its prior distribution (σD = 0.58)
as this possibly overestimates σD and in doing so lowers the chance of incorrectly declaring a point
as implausible whilst still ruling out a significant proportion of parameter space.
7.1 Iterative fitting of Gaussian processes
We used a sequential procedure for fitting the Gaussian process in order to make best use of the
limited computing resources available to simulate realisations from the stochastic model (Figure 3).
In what follows, we provide a brief description of this procedure and refer the reader to Appendix C
of the Supplementary Materials for further details.
We began in Wave 0 of the fitting procedure by constructing a 10K-point LHD within the
cuboid defined by the 11 univariate marginal 99% prior equi-tailed intervals for each parameter θj .
Multiple realisations (n = 1000) were then obtained from the stochastic model at these design
points to determine the empirical logit proportions of cell death and of inclusion bodies. Next we
eliminated those design points which gave proportions (of cell death or of inclusion bodies) outside
the range (0.01, 0.99), as such values look to be inconsistent with the data and they take considerable
computing time to obtain. Finally, in Wave 0, we fitted a Gaussian process (GP0) to the remaining
415 training points. Next, in Wave 1, we constructed an additional 10K-point LHD and removed any
design points which had predicted probabilities (of the form eexpit{m∗GP0(θi)}) outside (0.01, 0.99).
The points surviving Wave 0 were then added and any points with implausibilities IGP0(θi) > 3
removed. Note that these implausibilities were calculated using the Gaussian processes GP0 fitted
at the end of Wave 0. Multiple realisations from the stochastic model were then simulated at the
remaining 429 design points, empirical logits calculated and Gaussian processes GP1 fitted to this
output. In practice, this process could be repeated to give many more waves of history matching,
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and thereby narrow down the plausible parameter space even further. However, due to our limited
computer resources, we terminated our process with GP1.
7.2 Emulator validation
Before using the GP1 emulators as part of the inference scheme it is important to verify that they
provide an adequate description of model realisations of the empirical logits. There are a variety
of diagnostic checks available based on comparisons of realisations from the stochastic model at a
new set of design points (θ†i ) and comparing these with predictions made from the emulators; see,
for example, Bastos and O’Hagan (2009) and Gneiting et al. (2007).
We constructed a validation design of a similar size to that used for fitting the GP1 emulators
by repeating the Wave 0–1 procedure described in the previous section. This approach gives an
independent design but still contains points in regions of non-negligible posterior support, where
we most need the emulators to fit well. For each Gaussian process, we calculated individual pre-
diction errors (IPEs) at each design point as D(θ†i ) = {x(θ†i ) −m∗(θi†)}/
√
v∗(θ†i ), where x(θ
†
i ) is
an empirical logit (for a particular time-condition proportion) calculated from n = 1000 runs of
the stochastic model with rates θ = θ†i . Individual values of D(θ
†
i ) are informative about emulator
fit but it is particularly instructive to look at their overall distribution. If the assumptions under-
pinning the emulator are appropriate then the D(θ†i ) values should be a random sample from a
standard normal distribution. In particular, we would expect that roughly 95% of the IPE values
are within the interval (−2, 2). If the magnitude of the IPE is too large, this indicates that, at
this input point, the emulator either fits poorly or its variability is underestimated. Conversely,
too many very small values are indicative of an inflated emulator variance. Gneiting et al. (2007)
suggest that checks also be made using the probability integral transform (PIT) to assess the (stan-
dard) normality of the D(θ†i ) as, if this holds, values of Φ{D(θ†i )} should form a random sample
from a standard uniform distribution, where Φ(·) is the standard normal distribution function. The
IPEs for all 24 time-condition emulators are shown in Figure 4. Rather than produce additional
PIT plots we give boxplot summaries for each emulator and include horizontal lines showing the
positions of the quartiles and upper and lower 2.5% points of the standard normal distribution.
These and other plots (see Appendix D of the Supplementary Materials) suggest that there are no
strong departures from the univariate normal assumptions (1) used to form the likelihood function.
8 Posterior summaries and conclusions
To construct the emulators, training data (consisting of stochastic realisations from the model) were
generated in parallel on a high performance computer (HPC), with 64 compute nodes, where each
node had at least 128GB of RAM and a minimum processor speed of 2.5GHz. Hyper-parameter
inference was performed via the RStan interface to Stan, on a different HPC (with 23 cores and
a minimum processor speed of 2.70GHz). The total CPU time to obtain the fitted emulators was
approximately 1 day.
Realisations from the joint posterior distribution of all parameters of interest were obtained by
using the fitted emulators and again implemented via the RStan interface to Stan.
This MCMC algorithm uses the ‘no-U-Turn’ Hamiltonian Monte Carlo sampler which efficiently
explores the parameter space to maximise mixing. We ran three chains, each for 100K iterations,
and using different initialisations. For each chain, the first half (50K iterates) were discarded as
warm-up/adaptation and the remaining half were thinned to give 1K (almost) un-autocorrelated
realisations from the posterior distribution. Convergence was assessed by a variety of methods,
including graphical methods; see Appendix E in the Supplementary Materials for example trace-
plots and autocorrelation plots. We also examined diagnostics provided by the shinystan applica-
tion (Gabry, 2018). In particular, we looked at the potential scale reduction statistic Rˆ, which is
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Figure 4: Boxplots of the individual prediction errors for each emulator together with horizontal
lines showing the position of the quartiles and upper and lower 2.5% points of the standard normal
distribution.
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Figure 5: Marginal prior and posterior distributions for the (logged) stochastic kinetic rate param-
eters (histogram – posterior; red curve – prior).
the ratio of the within-chain variance and between-chain variance of the posterior sample (Gelman
and Rubin, 1992). Here an Rˆ-value close to one indicates that all chains have reached equilibrium,
and in our posterior sample, all parameters had values less than 1.1. We also found that, for all
parameters, the Monte Carlo standard errors was less than 10% of the posterior standard deviation
and the effective sample sizes greater than 10% of the total sample size. Running the MCMC
scheme for 100K iterations took approximately 7 days. Hence, the total computational cost (of
obtaining the fitted emulators and performing the final calibration task) is of the order of 8 days.
For comparison, consider use of the simulator directly inside an MCMC scheme. If we assume that
a single iteration takes 60 seconds, then 100K iteartions would take 70 days. We note that this
estimate is conservative, as in reality, the mixing of such a scheme may necessitate many more
iterations. Therefore, we expect that our use of emulators gives between one and two orders of
magnitude increase in computational savings.
Graphical summaries of the marginal posterior distributions of the (logged) kinetic rates are
given in Figure 5. The figure shows that, despite the experimental data being thought to perhaps
give only a very partial insight into the biological mechanism, it has in fact been very informative
about many parameters. The analysis has confirmed values, with very much increased precision, for
the rates of cell death due to activation of p38 (kp38death) and due to inhibition of the proteasome
by aggregates (kPIdeath), which were also observed but with no information on cause of death. It is
of particular note that the posterior distribution suggests that the early stages of the aggregation
process, when it is reversible, probably occur at a much faster rate than had previously been
assumed. This suggests that both the disaggregation of small aggregates and the formation and
early growth of aggregates are more rapid. Also the ratio of disaggregation and aggregation rates
(kdisaggPolyQ1/kaggPolyQ) is around an order of magnitude higher than was thought. This suggests
on the one hand that it may take longer to reach the threshold size required for inclusion formation
but also that there will be more small aggregates present which will inhibit the proteasome. The
decrease in posterior mean also suggests that proteasome inhibition (kinhprot) is likely to occur at a
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Figure 6: Marginal posterior distributions for the (logged) measurement error parameters (his-
togram – posterior; red curve – prior).
slower rate than first thought; probably due to originally underestimating the production of small
aggregates.
Looking at the rates involved in ROS turnover, the posterior suggests that the rate at which ROS
is removed (kremROS) is faster and that less ROS is generated by small aggregates (kgenROSAggP)
than was thought, which means that the generation of ROS via the p38 pathway probably plays
a larger contribution. This confirms the suggestion by Tang et al. (2010) that p38 inhibitors, an
experimental intervention that they tested, have therapeutic potential to reduce the detrimental
effects of the aggregation process.
Figure 6 shows summaries of the marginal posterior distributions of the (logged) measurement
error levels.
We have also looked at the overall adequacy of the stochastic and observational models by
comparing the observed proportions under the three conditions with their posterior predictive
distribution. These distributions can be determined by first running the stochastic model at a
sample of realisations from the posterior distribution of the model parameters and then obtaining
realisations from the observation model using this output. Figure 7 shows, for each experimental
condition, 95% predictive intervals for the proportions of cell death or inclusion bodies on the
logit scale, with the experimental data shown as crosses. The positions of the data points in
these intervals suggest that there are no obvious departures from the joint observation-biological
stochastic model, though there is, of course, scope for model refinement and further experiments.
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Supplementary Materials
Web Appendix 1 referenced in Sections 3, 7 and 8 is available upon request. The associated
computer code is available from
https://github.com/csgillespie/polyglutamine-inference
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